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Methods: Various grades of stenosis were created by
adhering different amounts of silicone rubber sealant onto
the inner wall of clear, radiolucent tubes. Following CTA,
MRA and DSA, the tubes were transected with 1-mm
interval through the plaques. The cross-sectional areas were
digitally photographed, and the percentage of area reduc-
tion of every single slide was measured using ImageJ plani-
metric software (Figure 1). The maximum actual area re-
duction (AAR) stenosis of each tube was recorded. The
differences among CTA, MRA, DSA, and AAR were com-
pared statistically.
Results: Overall, CTA andMRA significantly underes-
timated the degrees of stenosis compared with AAR
(p0.001 and p0.0009, respectively), and no significant
difference between DSA and AAR (p3.98). In the sub-
group with stenosis less than 70%, there was no significant
difference between CTA, MRA, and DSA versus AAR
(p0.16, p0.08, and p1.76, respectively). In the sub-
group with severe stenosis over 70%, CTA and MRA sig-
nificantly underestimated the stenosis versus AAR
(p0.004, and p0.007 respectively); and DSA signifi-
cantly overestimated the stenosis (p0.0007).
Conclusions: CTA, MRA, and DSA are consistent
with AAR in grading of mild to moderate stenosis. CTA
and MRA significantly underestimate, but DSA signifi-
cantly overestimates the percentages of severe stenotic le-
sions. Morphology of carotid plaques may affect the accu-
racy of imaging studies. Clinical correlation need to be
investigated.
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Objectives: Post-procedure microembolization dem-
onstrated on diffusion weighted MRI (DWI) has emerged
into a promising outcome measure for carotid interven-
tions. We previously demonstrated that technical modifica-
tions to our carotid stenting (CAS) program can reduce
microembolization. We sought to examine the impact of
these modifications on the incidence of microemboli in
patients who receive carotid revascularization procedures.
Methods: From 7/2004 to 6/2010, a total of 228
consecutive patients (143 CEA and 85 CAS) who under-
went carotid interventions also received pre- and post-
operative MRI evaluations in a single academic institution.
Prior to January 2007 (Period1) 41 patients underwent
CAS. After January 2007 (Period2), CAS was performed
using a closed-cell system, early heparinization, minimal
arch manipulation, and involvement of experienced physi-
cians. Hospital records for all patients were reviewed for
comorbidities, lesion characteristics, procedural informa-
tion, postoperative outcomes, and incidence of postproce-
dural microemboli.
Results: Forty (47%) CAS patients compared to 15
(10%) CEA patients had acute microemboli on postproce-
dural DWI (P0.001), and also had a higher incidence of
contralateral microembolization (P0.01,OR6). In Pe-
riod1 the incidence of microemboli in CAS patients was
59%, and in Period2 it was reduced to 36% (P0.01).
Multivariant analysis demonstrated that the strongest pre-
dictors of microembolization after CAS or CEA were
BMI30 (P0.001,OR11), history of coronary artery dis-
ease (P0.027,OR5), or the detection of infarcts on pre-
operative MRI, (P0.006,OR8).
Conclusions: Although the incidence of microembolic
events following CAS is higher compared to CEA, proce-
dural modifications to CAS along with appropriate patient
selection can help significantly decrease its occurrence.
Further investigational use of periprocedural DWI is
needed to determine the utility and cost-effectiveness of
identifying patients at risk of microembolic events.
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Objectives: The current Center for Medicare and
Medicaid Services (CMS) guidelines offer stenting as an
alternative largely in symptomatic patients with high-grade
stenosis considered “high risk” for carotid endarterectomy
(CEA).We stratified patients who underwent carotid artery
stenting (CAS) by CMS inclusion criteria and compared
their outcomes.
Methods: A retrospective chart review of all CAS pro-
cedures from 2001 through 2010 at our institution was
performed. Patients were identified using the SVS Registry
and electronic hospital records using ICD-9 codes and
stratified according to CMS risk factors. Data analysis in-
cluded multivariate logistic regression using physiologic
high-risk status, anatomic high-risk status, symptom status,
and gender as predictors. Combined 30-day CVA/TIA,
death, or MI served as the primary outcome.
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Results: Three hundred and seven CAS patients were
identified, of which 190 were considered high-risk (62%),
101 were physiologically high-risk (53%), 63 were anatom-
ically high-risk (33%), and 26 were both (14%). Ninety-six
patients were symptomatic (31%). Twenty-three patients
suffered complications (7.5%), including 9 CVAs (2.9%), 8
TIAs (2.6%), 4 MIs (1.3%), and 4 deaths (1.3%). Indepen-
dent predictors of CVA/TIA, death, or MI were physio-
logic high-risk status, symptomatic status, andmale gender,
while anatomic high-risk status was not (Table 1).
Conclusions: Current CMS physiologic high-risk
CEA criteria place patients at increased risk for adverse
events for CAS. This warrants the need for improved pa-
tient selection criteria for CAS vs. CEA in physiologically
high-risk patients.
Table 1. Results of multivariate logistic regression
analysis
OR CI p-Value
HR (Physiologic) 2.54 1.01-6.42 0.047
HR (Anatomic) 1.02 0.39-2.67 0.96
Symptomatic 3.77 1.54-9.26 0.004
Male Gender 3.22 1.04-9.95 0.042
HR, high-risk; OR, odds ratio; CI, confidence interval.
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Objectives: Cerebral hyperperfusion syndrome (CHS)
following carotid endarterectomy (CEA) is defined by a
combination of symptoms and at least a doubling of pre-
operative cerebral blood flow, correlated to a doubling of
the mean blood velocity (Vmean) measured in the ipsilat-
eral middle cerebral artery with transcranial Doppler
(TCD). Currently, an increase in Vmean of 100% 3
minutes after carotid declamping, compared to pre-clamp-
ing Vmean is the gold standard for CHS prediction. How-
ever, applying this method, not all patients at risk for CHS
are identified, while others may be treated unnecessarily.
We hypothesize that the positive predictive value (PPV) of
TCD in the prediction of CHS can be increased by an
additional post-operative TCD measurement within two
hours after CEA.
Methods: In 184 CEA patients the pre-operative (V1),
pre-clamping (V2), post-clamping (V3) and post-operative
Vmean (V4) was measured by TCD and standard blood
pressures were scored. The intra-operative Vmean increase
((V3 - V2) / V2) was compared to the post-operative
increase ((V4 - V1 )/ V1) in relation to CHS and post-
operative hypertension. Outcome was reported as PPV and
ROC-curve analysis.
Results: An intra-operative Vmean increase of 100%
was noted in 16 patients (9%), and a post-operative Vmean
increase in 22 (12%) patients. In 10 patients (5%) CHS was
diagnosed; two of those had an intra-operative Vmean
increase of 100% and nine a post-operative Vmean in-
crease 100%. This results in a PPV of 13% for the intra-
operative and 41% for the postoperative measurement, and
a PPV of 29% if both measurements were combined.
ROC curve analysis showed an area under the curve of
0.641 for the intra-operative and 0.904 for the post-oper-
ative Vmean measurement method.
Conclusions: A post-operative Vmean increase of
100% as measured by TCD is superior to both the intra-
operative and the combined intra- and post-operative TCD
measurement for the identification of patients at risk for the
development of CHS after CEA.
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Objectives: Cost-effectiveness has become an impor-
tant endpoint in comparing therapies considered to have
clinical equipoise. Prior economic analysis of carotid artery
treatment has been limited by small sample size.
Methods: A retrospective analysis of hospital cost and
30 day clinical outcomes was performed on patient under-
going carotid endarterectomy (CEA) and carotid stenting
with (CAS) between 1/1/08 - 9/30/10 at a single insti-
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